The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
A Rubio-San-SimónR Hladun AlvaroA Juan RibellesA Castañeda HerediaP Guerra-GarcíaJ Verdú-AmorósM AndrésA CañeteS RivesA Pérez-MartínezJ MoraA Patiño-GarcíaA LassaletaA LlortM RamírezC MataS GallegoJ Martín-BrotoO CruzA Morales La MadridP SolanoI Martínez RomeraA Fernández-TeijeiroFrancisco J Bautista SirventL MorenoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
The number of available trials, and the number of participating patients, has increased in Spain from 2007. Studies focused on molecular-specific targets are now being implemented. Barriers to accessing new drugs for all ranges of age and cancer diseases remain. Additionally, opportunities to improve academic research are still required in Spain.